Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Rejnmark

Showing results (31-40 of 264) with videos related to

Pageof 27
Sort By:
Contraception|May 30, 2006
Oral contraceptive use and risk of fracturesPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Scientifica|August 8, 2014
Therapy of hypoparathyroidism by replacement with parathyroid hormoneLars Rejnmark, Line Underbjerg, Tanja Sikjaer
Calcified Tissue International|April 17, 2008
Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fracturesPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Ugeskrift for Laeger|March 28, 2008
[Strongly increasing incidence of hip fractures in Denmark from 1977 to 1999]Peter Vestergaard, Lars Rejnmark, Leif Mosekilde
Endocrine|February 22, 2019
Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic reviewTorben Harsløf, Lars Rolighed, Lars Rejnmark
Current Drug Safety|April 29, 2011
Emerging anabolic treatments in osteoporosisLeif Mosekilde, Ove Tørring, Lars Rejnmark
Chest|September 25, 2007
Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroidsPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Calcified Tissue International|December 17, 2010
Are antiresorptive drugs effective against fractures in patients with diabetes?Peter Vestergaard, Lars Rejnmark, Leif Mosekilde
Archives of Dermatology|May 19, 2010
High-dose treatment with vitamin A analogues and risk of fracturesPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Calcified Tissue International|January 5, 2008
Anxiolytics and sedatives and risk of fractures: effects of half-lifePeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Pageof 27

Showing results (31-40 of 264) with videos related to

Sort By:
Pageof 27
Contraception|May 30, 2006
Oral contraceptive use and risk of fracturesPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Scientifica|August 8, 2014
Therapy of hypoparathyroidism by replacement with parathyroid hormoneLars Rejnmark, Line Underbjerg, Tanja Sikjaer
Calcified Tissue International|April 17, 2008
Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fracturesPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Ugeskrift for Laeger|March 28, 2008
[Strongly increasing incidence of hip fractures in Denmark from 1977 to 1999]Peter Vestergaard, Lars Rejnmark, Leif Mosekilde
Endocrine|February 22, 2019
Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic reviewTorben Harsløf, Lars Rolighed, Lars Rejnmark
Current Drug Safety|April 29, 2011
Emerging anabolic treatments in osteoporosisLeif Mosekilde, Ove Tørring, Lars Rejnmark
Chest|September 25, 2007
Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroidsPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Calcified Tissue International|December 17, 2010
Are antiresorptive drugs effective against fractures in patients with diabetes?Peter Vestergaard, Lars Rejnmark, Leif Mosekilde
Archives of Dermatology|May 19, 2010
High-dose treatment with vitamin A analogues and risk of fracturesPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Calcified Tissue International|January 5, 2008
Anxiolytics and sedatives and risk of fractures: effects of half-lifePeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Pageof 27